Poly(ethylene glycol) methyl ether (mPEG, Mn 1 kg/mol) was purchased from Rapp Polymers. 1,3-Dioxan-2-one (TCI Europe, 98%), 2,2-bis(hydroxymethyl)propionic acid (Sigma, 99%), trimethylamine (Sigma, 98%), bis(pentafluorophenyl) carbonate (Apollo scientific, 97%), cesium fluoride (CsF, Sigma 99%), cis-diamineplatinum(II) dichloride (TCI Europe), 1-(3-aminopropyl)imidazole (Sigma, 97%), hydrogen peroxide solution 30 % in H 2 O (Sigma), hexanoic anhydride (Sigma, 97%), Chlorin e6 (Frontier Scientific, 93%~98%), N,N'-dicyclohexylcarbodiimide (DCC, Sigma, 99%), 2-(dimethylamino)pyridine (DMAP, Sigma, 97%), methanesulfonic acid (MSA, Sigma, 99.5%), trifluoromethanesulfonic acid (Sigma, 99.5%), and all other chemicals were supplied by Sigma-Aldrich. Dulbecco's modified eagle medium (DMEM), phosphate buffered saline (PBS), Hoechst 33342 were purchased from ThermoFisher Scientific. Ultra-pure MilliQ water obtained from a Labconco Water Pro PS purification system (18.2 ME) was used for the self-assembly.
Synthetic procedures
Scheme S1. Synthesis route towards TMC monomers, poly-carbonates and functional poly-carbonates. 5 : This compound was synthesized according to the previous reported procedure. 1 A 100 mL round bottom flask was charged with 2,2-bis(hydroxymethyl)propionic acid (bis-MPA) (3.00 g, 22 mmol), bis-(pentafluorophenyl)carbonate (PFC) (21.70 g, 55 mmol, 2.5 eq.), CsF (0.7 g, 4.6 mmol, 0.2 eq.), and 70 mL of anhydrous tetrahydrofuran (THF). Initially the reaction was heterogeneous, but after one hour a clear homogeneous solution was formed that was allowed to stir for 20 hours. The solvent was removed in vacuo. The residue was re-dissolved in methylene chloride and, after 10 min, a byproduct precipitated and could be quantitatively recovered. The filtrate was extracted with sodium bicarbonate and water and was dried with MgSO 4 . The solvent was evaporated in vacuum and the product was recrystallized from ethyl acetate/hexane mixture to give TMC-OPh5 as a white crystalline powder. Yield: 5.13 g (70 % yield). 1 
Synthesis of TMC-OPh

Synthesis of PEG 22 -TMC-TMCI:
(1) PEG-PTMC synthesis: Taking PEG 22 PTMC 30 as an example, the synthesis of PEG-PTMC was performed according to a modified literature procedure. 1 Monomethyl-PEG-OH macro-initiator 1 KDa (524 mg, 0.5 mmol, 1 equiv) and 1,3-dioxan-2-one (TMC) (1.53 g, 15 mmol, 30 equiv) were added into a round bottom flask. To avoid water presence, dried toluene was added to the reaction flask and then the solvent was evaporated under vacuum. After solvent evaporation, the reaction flask was flushed with Ar. Dichloromethane was added to the mixture with a syringe and the resulting stirring solution was equilibrated at 30 °C for several minutes.
Then methanesulfonic acid (0.5 equiv, 16 µL) was added in the solution to start the reaction. After 2 h, Ar was stopped and the reaction was stirred and heated at 30 °C overnight. 1 H NMR was used to determine the final conversion of the reaction. Extraction was performed using DCM (to dissolve copolymer), NaHCO 3 twice (to remove catalyst) and brine (to remove water) once, keeping the lower organic phase. The resultant organic phase was collected and dried with sodium sulfate powder. The mixture was filtered over a glass filter and the filtrate was concentrated under vacuum. Stirred anhydrous ether was cooled down with liquid nitrogen and an ice bath. Droplets of the concentrated DCM solution were added to the stirring ether solution to precipitate the copolymer. The mixture was stirred for about 30 min, and subsequently collected via filtration. The pure product was obtained via freeze drying from dioxane and kept in the freezer until being used. The copolymer composition was calculated by using the protons of PEG (3.65-3.7 ppm) , terminal methyl unit (singlet at 3.38 ppm), TMC CH 2 (multiplet 2.02-2.08) and CH 2 (triplex at 4.22-4.25 ppm) . GPC (RI): M n (PDI) = 5.63 kDa (1.08) (Figure S10 , Table S3 ). PEG 22 PTMC 23 was synthesized using the same synthetic method, the copolymer composition was calculated by using the protons of PEG (3.65-3.7 ppm) , terminal methyl unit (singlet at 3.38 ppm), TMC CH 2 (multiplet 2.02-2.08) and CH 2 (triplex at 4.22-4.25 ppm), GPC (RI): M n (PDI) = 5.17 kDa (1.08) (Figure S7 , Table S3 ).
(2) PEG-PTMC-P(TMC-OPhF 5 ) synthesis: Taking PEG 22 PTMC 30 P(TMC-OPhF 5 ) 7 synthesis as an example, freeze dried PEG 22 -PTMC 30 (800 mg, 0.2 mmol, 1 equiv) and dry TMC-OPhF 5 (524.5 mg, 1.6 mmol, 8 equiv) was added into a round bottom flask. Under Ar, 1.6 mL DCM (1 M with respect to TMCP) was added into the flask. The TMCP only partially dissolves at this concentration. Triflic acid (34 µL, 0.4 mmol, 2 equiv) was added to the stirring solution. As the reaction proceeded, the undissolved PTMCP slowly went into solution.
The reaction was monitored by 1 H NMR. Once the reaction was complete, the polymer was precipitated into hexanes. The crude polymer was then re-dissolved in minimal amount of DCM and precipitated into diethyl ether, isolated, and freeze dried to obtain the product, and kept in the freezer until being used. Copolymer composition was calculated by using the protons of PEG (3.65-3.7 10 were synthesized using the same synthetic method, GPC (RI) for PEG 22 PTMC 23 P(TMC-OPhF 5 ) 7 : M n (PDI) = 8.22 kDa (1.10) ( Figure S8 , Table   S3 ); GPC (RI) for PEG 22 PTMC 30 P(TMC-OPhF 5 ) 10 : M n (PDI) = 8.93 kDa (1.12) ( Figure S13 , Table S3 ).
(3) Synthesis of PEG 22 -TMC-TMCI: Taking PEG 22 -TMC 30 -TMCI 7 as an example, freeze dried PEG 22 PTMC 30 P(TMC-OPhF 5 ) 7 (120 mg, 0.02 mmol, 1 equiv) was dissolved in 1 ml dry THF and cooled on an ice-bath. Next, a 0.5 mL THF solution containing 1-(3-aminopropyl)imidazole (20 mg, 0.16 mmol, 1.15 equiv respect to pentafluorophenyl ester) and trimethylamine (TEA, 22.3 µL, 0.16 mmol, 1.15 equiv. with respect to the pentafluorophenyl ester) was dropwise added. The ice bath was removed and the mixture was allowed to stir for an additional 90 minutes, after which the reaction solution was precipitated into diethyl ether twice, isolated and freeze dried to obtain PEG 22 -TMC 30 -TMCI 7 . Copolymer composition was calculated by using the protons of PEG (3.65-3.7 (3 singlets 7.56 ppm, 7.11 ppm, 6 .97 ppm) ( Figure S12 ). PEG 22 -TMC 23 -TMCI 7 and PEG 22 -TMC 30 -TMCI 10 were synthesized using the same route, Copolymer composition was calculated by using the protons of PEG (3.65-3.7 Figure S9 and Figure S14 ).
Synthesis of PEG 22 -TMCI-TMC
(1) PEG-P(TMC-OPhF 5 )-PTMC synthesis: Taking PEG 22 -P(TMC-OPhF 5 ) 7 -PTMC 30 as an example, the synthesis of PEG-P(TMC-OPhF 5 )-TMC was performed according to a modified literature procedure. 1 PEG 1 KDa (524 mg, 0.5 mmol, 1 equiv) and TMC-OPhF 5 (1.30 g, 4 mmol, 8 equiv) were added into a round bottom flask. To avoid water presence, dried toluene was added to the reaction flask and then the solvent was evaporated under vacuum. After solvent evaporation, the reaction flask was flushed with Ar. Dichloromethane was added to the mixture with a syringe, Under Ar, 4 mL DCM (1 M with respect to TMCP) was added into the flask. The TMCP only partially dissolves at this concentration. Triflic acid (85 µL, 0.4 mmol, 2 equiv) was added to the stirring solution. As the reaction proceeded, the undissolved PTMCP slowly went into solution.
The reaction was monitored by 1 H NMR. Once the conversion rate of TMC-OPhF5 was reached at or above 98%, a dry DCM solution of TMC (1.53 g, 15 mmol, 30 equiv) was added via a syringe and allowed to react overnight. When the conversion of TMC reached 95% or higher, the reaction was stopped. The crude polymer was directly precipitated into diethyl ether twice, isolated, and freeze dried to obtain the product. Copolymer composition was calculated by using the protons of PEG (3.65-3.7 Table   S3 ). PEG 22 -P(TMC-OPhF 5 ) 10 -TMC 32 was synthesized using same synthetic method. Copolymer composition was calculated by using the protons of PEG (3.65-3.7 Table S3 ).
(2) PEG 22 -TMCI-TMC synthesis: Freeze dried PEG 22 -P(TMC-OPhF 5 ) 7 -TMC 30 (120 mg, 0.02 mmol, 1 equiv) was dissolved in 1 ml dry THF and cooled on an ice-bath. Next, a 0.5 mL THF solution containing 1-(3-aminopropyl)imidazole (20 mg, 0.16 mmol, 1.15 equiv. with respect to the pentafluorophenyl ester) and trimethylamine (TEA, 22.3 µL, 0.16 mmol, 1.15 equiv. with respect to the pentafluorophenyl ester) were dropwise added. The ice bath was removed and the mixture was allowed to stir for an additional 90 minutes, after which the reaction solution was precipitated into diethyl ether twice, isolated and freeze dried to obtain PEG 22 -TMCI 7 -TMC 30 . Copolymer composition was calculated by using the protons of PEG (3.65-3.7 Figure   S16 ). PEG 22 -TMCI 10 -TMC 30 was synthesize using the same reaction routes. Copolymer composition was calculated by using the protons of PEG (3.65-3.7 Figure S18 ).
Synthesis of PEG 22 -(TMCI-r-TMC)
1) PEG-P[(TMC-OPhF 5 )-r-TMC] synthesis: the synthesis of PEG-P[(TMC-OPhF 5 ) 10 -r-TMC 30 ] was performed according to a modified literature procedure. 1 PEG 1 KDa (524 mg, 0.5 mmol, 1 equiv), TMC-OPhF 5 (1.95 g, 6 mmol, 12 equiv) and TMC (1.53 g, 15 mmol, 30 equiv) were added into a round bottom flask. To avoid water presence, dried toluene was added to the reaction flask and then the solvent was evaporated under vacuum. After solvent evaporation, the reaction flask was flushed with Ar. Dichloromethane was added to the mixture with a syringe, Under Ar, 4 mL DCM (1 M with respect to TMCP) was added into the flask. The TMCP only partially dissolves at this concentration. Triflic acid (85 µL, 0.4 mmol, 2 equiv) was added to the stirring solution. As the reaction proceeded, the undissolved PTMCP slowly went into solution. The reaction was monitored by 1 H NMR. Once the conversion of TMC-OPhF5 and TMC reached 95% or higher, the reaction was stopped. The crude polymer was directly precipitated into diethyl ether twice, isolated, and freeze dried to obtain the product. Copolymer composition was calculated by using the protons of PEG (3.65-3.7 ppm), terminal methyl unit (singlet at 3.38 ppm), TMC CH 2 (multiplet, 2.02-2.08 ppm) and CH 2 (triplex at 4.22-4.25 ppm), TMC(O-PhF 5 ) CH 2 (singlet, 4.44-4.48) , TMC(O-PhF 5 ) CH 3 (singlet, 1.48-1.50). GPC (RI): M n (PDI) = 9.00 kDa (1.3) ( Figure S19 ).
(2) PEG 22 -(TMCI-r-TMC) synthesis: Freeze dried PEG-P[(TMC-OPhF 5 ) 10 -r-TMC 30 ] (145 mg, 0.02 mmol, 1 equiv.) was dissolved in 1 ml dry THF and cooled on an ice-bath. Next, a 0.5 mL THF solution containing 1-(3-aminopropyl)imidazole (20 mg, 0.16 mmol, 1.15 equiv. with respect to pentafluorophenyl ester) and trimethylamine (TEA, 22.3 µL, 0.16 mmol, 1.15 equiv. with respect to pentafluorophenyl ester) were dropwise added. The ice bath was removed and the mixture was allowed to stir for an additional 90 minutes, after which the reaction solution was precipitated into diethyl ether twice, isolated and freeze dried to obtain PEG 22 -(TMCI 10 -r-TMC 30 ). Copolymer composition was calculated by using the protons of PEG (3.65-3.7 Figure   S20 ).
Synthesis of cisplatin prodrug:
The cisplatin prodrug was synthesized following previous reported procedures. 2 
Synthesis of a dye labeled polymer (PEG 22 -PTMC 30 -Ce6):
The chlorin e6 (Ce6) functionalized polymer was synthesized via a reported procedure with a slight modification. 3 Dried PEG-PTMC (2 g, 0.5 mmol), chlorin e6 (0.447 g, 0.75 mmol), DCC (0.412 g, 2 mmol), DIPEA (0.650 g, 5 mmol) and DMAP (0.244 g, 0.2 mmol) were dissolved in 20 mL DMSO and stirred for 48 h at 25 °C. After the reaction, the precipitated dicyclohexylurea (DCU) was filtered off and the mixture was dialysis against DMSO for 2 days and dioxane for 1 day. The obtained mixture was cooled down with liquid nitrogen and freeze dried. The product was characterized by 1 H NMR, UV-Vis analysis and SEC ( Figure S21 ).
Nanoparticle formation and acidity induced transformation
Direct hydration for the nanoparticle formulation: A solution of P 22 -TMCI-TMC or P 22 -TMC-TMCI in PEG-350 was prepared at 10 wt.% (40 mg of copolymer can be weighed into Eppendorf with 360 mg of PEG-350; heating at 40 °C and thorough mixing with a Gilson Microman E pipette (essential for this work) will aid in copolymer dissolution . After mixing and then spinning down the copolymer solution, 10 µL was placed at the bottom of a glass vial and, with gentle stirring at around 250 rpm, 90 µL of PBS buffer (pH7.4) was added.
After 5 min of mixing a cloudy suspension was formed and subsequently diluted by adding 900 µL of PBS buffer to give a nanoparticle suspension at 1 mg/mL [copolymer]). 
Acidity-induced transformation:
Experiments were performed in cuvettes by addition of a concentrated HCl solution (0.01 M) to a 1 mL solution of the nanoparticles in pH 7.4 PBS formed via the above direct hydration method, to achieve the desired pH . The size change and surface zeta potential were measured real time by DLS. Samples at certain time points were extracted for SEM, cryo-TEM, and AF4 measurements.
Critical aggregation concentration (CAC) determination:
The CAC determination was performed via an ANS fluorescence assay. A 1 mg/ml nanoparticle solution was prepared first, then diluted to 0.9, 0.8, 0.7, 0.6, 
Drug loading and release profile
A solution of cisplatin prodrug in PEG-350 was prepared at 10 wt.% (40 mg of cisplatin prodrug was weighed into an Eppendorf tube with 360 mg of PEG-350; heating at 40 °C and thorough mixing with a Gilson Microman E pipettes (essential for this work) was performed to ensure copolymer dissolution . To load the cisplatin prodrug in the nanoparticles, 2 L of the cisplatin prodrug in PEG-350 (10 wt. %) was mixed with 20 L of the polymer in PEG350 and heated at 40 °C. Then the mixture was placed at the bottom of a glass vial and, with gentle stirring at around 250 rpm, 180 µL of PBS buffer (pH 7.4) was added. After 5 min of mixing, 800 µL PBS buffer was added to dilute the sample. Cisplatin prodrug loaded nanoparticles were obtained after centrifuge separation via ultrafiltration (Cut-off 10 kDa). The amount of unencapsulated cisplatin prodrug in the dialysate was quantitatively measured by a UV-vis method following a reported procedure. 4 The drug encapsulation was calculated by the following equation:
Encapsulation Efficiency (%) = (m drug-loaded / m drug ) 100 m drug-loaded and m drug are amounts of drug encapsulated in the nanoparticles and total drug added, respectively.
Free cisplatin prodrug solution was obtained by dissolving 2 L cisplatin prodrug (in PEG350) in 1 mL PBS buffer.
For the drug release profile, 2 mL of drug-loaded nanoparticles in the dialysis bag (Cut-off 3.5 KDa) was added into 18 mL of pH 7.4, pH 6.5 or pH 5.5 PBS at 37 °C. At specified time intervals, the concentration of Pt was measured by a UV-vis method following reported procedures. 4
Cytotoxicity evaluation
HepG2 and HeLa cells were cultured in DMEM medium containing 10 % FBS, 1 % penicillin/streptomycin (complete DMEM) in 5 % CO 2 at 37 °C. The relative cell viability in presence of different compounds (nanoparticles, prodrug loaded nanoparticles, and free prodrug) was evaluated in vitro by an MTT assay. The cells were seeded in 96-well plates at a density of 5 × 10 3 cells per well in 100 μL complete DMEM medium and cultured for 24 h at 37 °C. Subsequently, the cells were incubated with the corresponding compounds at different concentrations for 24, or 48 h, respectively. The cells were washed and fresh medium containing MTT was added into each plate. The cells were incubated for another 4 h. After removing the medium containing MTT, dimethyl sulfoxide (100 μL) was added to each well to dissolve the formazan crystals. Finally, the plate was gently shaken for 5 min and the absorbance at 490 nm was recorded with a micro-plate reader.
Cellular uptake studies
Fluorescent imaging study: HepG2 cells were cultured in DMEM medium containing 10 % FBS, 1 % penicillin/streptomycin (complete DMEM) in 5 % CO 2 at 37 °C. HepG2 cells were seeded in a 96-well bottom black plate for 24 h, and then the medium was refreshed . The cells were treated with dye labeled nanoparticles (50 µg/ml) for 0.5, 1 and 2 h, respectively at pH 7.4 and pH 6.5. After a specific incubation time, the medium was removed, and the cells were washed with PBS buffer (pH 7.4) three times. Thereafter, the cells were stained with Hoechst 33342 for 10 min and fixed with 4.0 % formaldehyde at room temperature for 15 min. After 4.0 % formaldehyde was removed and the cells were washed with PBS buffer (pH 7.4) three times, the fluorescence images of the cells were captured using a Keyence BZ-9000 fluor-microscope or Leica TCS SP5X with different channels.
Flow cytometry study: HepG2 cells were cultured in DMEM medium containing 10 % FBS, 1 % penicillin/streptomycin in 5 % CO 2 at 37 °C. HepG2 cells were seeded in 6-well plates (1 × 10 5 cells/well) and cultured in complete medium for 24 h. The cells were treated with dye labeled nanoparticles (50 µg/ml) for 0.5, 1 and 2 h, respectively at pH 7.4 and pH 6.5. Then the cells were washed with medium, subsequently harvested and washed two times with cold PBS and re-suspended in 500 μL PBS. Finally, cells were analyzed by a flow cytometer (Beckman Coulter Cytomics Altra).
Penetration studies with 3D multicellular spheroids (MTSs)
3D multi-cellular spheroids (MCSs) were prepared according to a literature procedure 5 with slight modifications. Agarose coated 96-well plates were prepared first. In detail, 0.15 g of agarose was added to 10 ml of low glucose DMEM (1.5% wt/vol) in an appropriate beaker, sealed with aluminum foil or a lid and autoclaved for 20 min at 120 o C. Next 50 µl of the hot (80~90 o C) solution was added to each well of a 96-well plate (flat bottomed) under sterile conditions. The agarose solidified within seconds to minutes to produce a concave surface. HepG2 cells (200 μL, 1 × 10 4 cells mL −1 in high glucose DMEM medium) or a mixture of NIH 3T3 cells and HepG2 cells (5:1 ratio, 200 μL, 6 × 10 4 cells mL −1 in high glucose DMEM medium) were cultured in the above agarose-coated 96-wel plates, followed by incubation at 37 °C with 5% CO 2 humidified atmosphere for 4 days for the production of MCSs. Then the MCSs were treated with dye labeled nanoparticles for 2 h or 18 h at pH 7.4 and pH 6.5. The MCSs was carefully washed with cold PBS and observed with CLSM. Table S1 : General method for the AF4 analysis of MLNs. The flow conditions applied were the following:
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0.7 mL min -1 detector flow, 1.50 mL min -1 focus flow and 0.20 mL min -1 injection flow.
Start time (min) End time (min) Mode Cross flow start (mL min -1 ) Cross flow end (mL min -1 ) Table S2 : General method for the AF4 analysis of CNs. The flow conditions applied were the following:
0.7 mL min -1 detector flow, 1.50 mL min -1 focus flow and 0.20 mL min -1 injection flow. Integrated fluorescence intensity of penetration at each scanning depth;
